Promoting regeneration while blocking cell death preserves motor neuron function in a model of ALS

Area of Science:

• Neuroscience
• Neurodegenerative disease research
• Molecular biology

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease with limited treatments.
• Dual leucine zipper kinase (DLK) deletion previously delayed motor neuron degeneration in ALS models.
• DLK also plays a role in axon regeneration, suggesting a potential for combined therapeutic strategies.

Purpose of the Study:

• To investigate the synergistic effects of combining DLK deletion with ATF3-mediated axon regeneration promotion in an ALS mouse model.
• To determine if this combinatorial approach offers enhanced motor neuron protection compared to individual strategies.

Main Methods:

• Utilized a mouse model of ALS (SOD1G93A).
• Employed a mouse line with constitutive ATF3 expression, a key regeneration regulator.
• Combined DLK deletion with ATF3 expression in the SOD1G93A mouse model.
• Assessed motor neuron health and function using electrophysiology, histology, and behavioral analysis.

Main Results:

• Observed a powerful synergistic effect between DLK deletion and ATF3 expression.
• Demonstrated significant protection of motor neurons, with reduced cell death and axon degeneration.
• Preserved motor function and neuromuscular connectivity in the treated mice.

Conclusions:

• Combinatorial therapy targeting DLK inhibition and promoting axon regeneration (via ATF3) is highly effective in an ALS mouse model.
• This dual-strategy approach offers a promising therapeutic avenue for neurodegenerative diseases like ALS.
• Highlights the potential of combining distinct therapeutic mechanisms for enhanced treatment outcomes.